Effect of Clostridium toxoids, especially of Clostridium perfringens toxoid, on mouse transplanted tumors.
The antitumor activities of toxoids of Clostridium perfringens, C. nouyi, C. septicum, and C. tetani were tested against sarcoma-180 and Ehrlich carcinoma. Among them, C. perfringens toxoid showed a high antitumor activity against the growth of the implanted sarcoma-180 ascites form. The results of the inhibiting effect of C. perfringens toxoid on Nakahara-Tokuzen-Fukuoka (NTF) reticulum cell sarcoma and methylcholanthrene-induced fibrosarcoma were also described.
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000628:therapy; D003013:Clostridium; D003016:Clostridium perfringens; D003017:Clostridium tetani; D005260:Female; D005354:Fibrosarcoma / Q000628:therapy; D007167:Immunotherapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy; D051379:Mice; D008813:Mice, Inbred ICR; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000628:therapy*; D012510:Sarcoma 180 / Q000628:therapy; D012513:Sarcoma, Experimental / Q000628:therapy; D014121:Toxoids / Q000302:isolation & purification
D014121:Toxoids